Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
A Phase I/IIa, Dose Escalation Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Intraductal Administration of RXRG001 to Parotid Gland(s) in Adults With Radiation-Induced Xerostomia and Hyposalivation
This is a first-in-human clinical study to evaluate the safety, tolerability and efficacy of RXRG001 administered in the ducts of the parotid glands in adult p…
Radiation-Induced Xerostomia and Hyposalivation
Estimated
~$10 – $8,750
RiboX Therapeutics Ltd.NCT06714253
Phase 1
A Phase I Study of d-Limonene With Concurrent Radiation and Platinum Based Chemotherapy for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
This study explores the safety of d-limonene, a commercially-available dietary supplement (food) as a potential therapeutic for the severe dry mouth (xerostomi…
Xerostomia
Estimated
~$10 – $6,250
Stanford UniversityNCT04392622
Phase 1
UW23129: A Phase I Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
The goal of this clinical trial is to evaluate the safety and tolerability of injecting certain cells produced in bone marrow called mesenchymal stromal cells …
XerostomiaGraft-versus-host-diseaseSjogren's Disease
Estimated
~$10 – $6,250
University of Wisconsin, MadisonNCT06392711